<?xml version="1.0" encoding="UTF-8"?>
<p id="p0340">Immune responses to influenza vaccination are likely more effective further out from HCT. HCT recipients 6 months or older should receive IIV annually starting 6 months after transplant or starting 4 months after transplant during a community outbreak of influenza,
 <xref rid="bib_23" ref-type="bibr">
  <sup>23</sup>
 </xref> with second doses recommended for children depending on time from transplant. In reduced intensity HCT, pretransplant vaccination may be appropriate as host immunity is expected to extend into the early transplant period. High-dose vaccination is currently under study in pediatric and adult HCT recipients.
</p>
